[ Price : $8.95]
A OneKey analysis of healthcare practitioner use of social media finds that oncologists are more active in social media than other...[ Price : $8.95]
Celltex Therapeutics says it will appeal a recent FDA decision that the process it uses to multiply adult stem cells is subject to...[ Price : $8.95]
An FDA-commissioned bioequivalence study of Tevas Budeprion XL 300mg ends six years of controversy over adverse effects in patient...[ Price : $8.95]
A new study says that pediatric drug exclusivity strategies can see a return-on-investment on average of $130 for every $1 spent.[ Price : $8.95]
A Florida federal judge grants a Medtronic motion to dismiss on preemption grounds in a product liability suit involving the compa...[ Price : $8.95]
FDA tells Celgene that it has canceled an 11/8 Oncologic Drugs Advisory Committee meeting that was intended to review the companys...[ Price : $8.95]
Reckitt Benckiser petitions FDA to take steps to ensure pediatric safety with drug products containing buprenorphine for treating ...[ Price : $8.95]
Retraction Watch says a new study published in the Proceedings of the National Academy of Sciences demonstrates that fraud plays a...